Correlation Between Fidelity Advisor and Biotechnology Portfolio

Can any of the company-specific risk be diversified away by investing in both Fidelity Advisor and Biotechnology Portfolio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fidelity Advisor and Biotechnology Portfolio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Fidelity Advisor Health and Biotechnology Portfolio Biotechnology, you can compare the effects of market volatilities on Fidelity Advisor and Biotechnology Portfolio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fidelity Advisor with a short position of Biotechnology Portfolio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fidelity Advisor and Biotechnology Portfolio.

Diversification Opportunities for Fidelity Advisor and Biotechnology Portfolio

0.69

Correlation Coefficient

Fidelity Advisor  Biotechnology Portfolio

Poor diversification

The 3 months correlation between Fidelity and Biotechnology is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Fidelity Advisor Health and Biotechnology Portfolio Biotec in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotechnology Portfolio and Fidelity Advisor is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fidelity Advisor Health are associated (or correlated) with Biotechnology Portfolio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotechnology Portfolio has no effect on the direction of Fidelity Advisor i.e., Fidelity Advisor and Biotechnology Portfolio go up and down completely randomly.

Pair Corralation between Fidelity Advisor and Biotechnology Portfolio

Assuming the 90 days horizon Fidelity Advisor Health is expected to generate 0.68 times more return on investment than Biotechnology Portfolio. However, Fidelity Advisor Health is 1.47 times less risky than Biotechnology Portfolio. It trades about -0.12 of its potential returns per unit of risk. Biotechnology Portfolio Biotechnology is currently generating about -0.11 per unit of risk. If you would invest  7,639  in Fidelity Advisor Health on September 15, 2024 and sell it today you would lose (512.00) from holding Fidelity Advisor Health or give up 6.7% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Fidelity Advisor Health  vs.  Biotechnology Portfolio Biotec

Fidelity Advisor Health

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Fidelity Advisor Health has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's forward indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.

Biotechnology Portfolio

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Biotechnology Portfolio Biotechnology has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.

Pair Trading with Fidelity Advisor and Biotechnology Portfolio

The main advantage of trading using opposite Fidelity Advisor and Biotechnology Portfolio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fidelity Advisor position performs unexpectedly, Biotechnology Portfolio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotechnology Portfolio will offset losses from the drop in Biotechnology Portfolio's long position.

The idea behind Fidelity Advisor Health and Biotechnology Portfolio Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.